Elutia

ELUTNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$37.577 M

$0.85 -3.52%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$53.4M

#1548 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

0.7

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#132Metagenomi TherapeuticsMGX$46.3M
#133TevogenTVGN$41.5M
#134ElutiaELUT$37.6M
#135Dyadic InternationalDYAI$36.4M
#136Aligos TherapeuticsALGS$34.6M

Where these numbers come from

Share counts and financials for Elutia are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.